IS THE INTERNATIONAL PROGNOSTIC INDEX FOR AGGRESSIVE LYMPHOMAS USEFULFOR LOW-GRADE LYMPHOMA PATIENTS - APPLICABILITY TO STAGE III-IV PATIENTS

Background The International Prognostic Index (IPI) is widely used to predict outcome of patients with aggressive lymphomas. Our goal was to assess the prognostic value of this index for low-grade lymphoma. Pat ients and methods: One hundred eighty-two patients with disseminated ( stage III or IV) low-grade lymphoma were enrolled in a prospective mul ticenter trial. According to the initial features, treatment either wa s started immediately or was deferred until indicated by disease progr ession. Patients received the same polychemotherapy regimen, given mon thly for six cycles. They were assigned to one of four risk groups acc ording to the number of presenting risk factors: low-risk (0 or 1), lo w-intermediate-risk (2), high-intermediate-risk (3), high-risk groups (4). Results: Survival curves (Kaplan-Meier method) demonstrated a hig h significant difference for the four groups (log-rank: P < 0.0001). M edian survival for the low-risk group has yet to be reached, while tha t for the three other groups are, respectively, 65, 34, and 12 months. Conclusions: In this study, the IPI has been found to be an important prognostic tool in low-grade lymphoma and may be used in the selectio n of appropriate therapeutic approaches for individual patients.